Default company panoramic image

INDS, Inc.

Multidisciplinary team of drug development and IT experts providing nonclinical pharmaceutical development support and informatics tools.

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location Ann Arbor, MI, USA
  • Currency USD
  • Founded April 2007
  • Employees 8
  • Website

Company Summary

INDS is an innovative, experienced team with specialized, complementary expertise that delivers professional pharmaceutical development consulting and information technology solutions to pharma companies. Our nonclinical development experts provide cost- and time-efficient drug development program designs, program management, safety issue analysis and resolution strategies, regulatory submission preparation, due diligence services and IT tools.


  • Default avatar
    James R. Herman
    Partner and President

    Jim has 25 years of nonclinical drug safety research and development experience that included tactical and strategic support of nonclinical development projects and successive managerial appointments. Jim has significant experience in the regulatory toxicology field (US, EU, and Japan), and has contributed to over 100 IND and NDA submissions including, during his time at Pfizer/Warner-Lambert, those for Lipitor, Neurontin, and Lyrica.

  • Default avatar
    Steven K. Duddy
    Partner and Chief Scientific Officer

    Steve has over 25 years of toxicology experience, including key roles as a drug development team representative for multiple therapeutic areas, and developing and implementing experimental and regulatory strategies to support development of promising preclinical drug candidates. Prior to cofounding INDS in 2007, Steve was an Associate Research Fellow in Drug Safety Research &Development, Pfizer Global Research and Development in Ann Arbor, MI.

  • Default avatar
    Joyce C. Zandee
    Partner and Chief Operating Officer

    Joyce, a certified project manager (PMP), has over 20 years of experience in drug safety, focused on data analysis and visualization, data warehousing, report automation, resource analysis, and business modeling. Prior to cofounding INDS, Joyce was Director of Business & Project Management, Site Operations Lead, and then Global Performance Excellence site lead in the Drug Safety department at Pfizer Global Research & Development in Ann Arbor, MI.

  • Default avatar
    Marc B. Bailie
    Partner and Chief Development Officer

    A founding partner of INDS, Marc previously led the Safety Pharmacology Group at Pfizer, Ann Arbor, and has served as a safety pharmacology expert within and outside of Pfizer. Marc was a key member of numerous Discovery and Development project teams and he has extensive experience evaluating the pharmacologic and toxicologic activity of drug candidates. Marc also contributed to the first filing of a novel Exploratory IND paradigm with the FDA.


  • Default avatar
    Default avatar
    Stefforia, Petik and Associates

Previous Investors

  • Default avatar
    NA - self funded by founding Partners